Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vbi Vaccines Inc CS
(NQ:
VBIV
)
0.6300
+0.0351 (+5.90%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
370,232
Open
0.5900
Bid (Size)
0.6003 (13)
Ask (Size)
0.6300 (50)
Prev. Close
0.5949
Today's Range
0.5700 - 0.6334
52wk Range
0.4500 - 1.450
Shares Outstanding
28,682,275
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
VBI Vaccines Announces Results of Annual General Meeting
June 25, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
May 29, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Performance
YTD
+2.26%
+2.26%
1 Month
+5.35%
+5.35%
3 Month
+4.48%
+4.48%
6 Month
+4.79%
+4.79%
1 Year
-53.68%
-53.68%
More News
Read More
VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
May 22, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Via
InvestorPlace
VBI Vaccines Reports First Quarter 2024 Financial Results
May 15, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
April 16, 2024
Via
InvestorPlace
VBI Vaccines Reports Full Year 2023 Financial Results
April 16, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 11, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 09, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
April 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 05, 2024
Via
InvestorPlace
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
April 03, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
April 02, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 14, 2024
Via
Benzinga
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
February 14, 2024
Via
Benzinga
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
February 14, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 24, 2023
Via
Benzinga
VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting
November 20, 2023
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Reports Third Quarter 2023 Financial Results
November 14, 2023
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine Program
October 26, 2023
From
VBI Vaccines Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
Via
Benzinga
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 27, 2023
Via
Benzinga
VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of Concern
September 27, 2023
From
VBI Vaccines Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.